Articles by Nooshine Dayani - Pharmaceutical Executive


Articles by Nooshine Dayani

Nooshine Dayani

Balancing Act
September 1, 2006

To faciliate the change process, companies must educate MSLs and reps to stay out of the grant-submission process. The new roles and job description should reflect this new regulatory landscape.


Click here